Skip to main content

Timothy Henn

Redwood City, California-based molecular diagnostics firm CardioDx has named Timothy Henn CFO. He most recently served as CFO of Crescendo Biosciences, which was acquired by Myriad Genetics in 2014. Henn has also held senior finance positions with Monogram Bioscience and Incyte.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.